Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Canaccord Genuity Initiates Coverage of Intellia Therapeutics (NTLA) with Buy Recommendation
Fintel reports that on April 13, 2023, Canaccord Genuity initiated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Buy recommendation. Analyst Price Forecast Suggests 181.05% Upside
Guru Fundamental Report for NTLA – Benjamin Graham
Below is Validea’s guru fundamental report for INTELLIA THERAPEUTICS INC (NTLA). Of the 22 guru strategies we follow, NTLA rates highest using our Value Investor